RBM34 antibody
Principal name
RBM34 antibody
Alternative names for RBM34 antibody
RNA-binding protein 34, KIAA0117, RNA-binding motif protein 34
Ncbi ID
9606, NP_055829, NP_001155005.1, NM_015014, NP_766350.2, NM_172762, NM_001014015, NM_001161533
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of RBM34 antibody
- Kit Component:
- - KN314566G1, Rbm34 gRNA vector 1 in pCas-Guide vector
- KN314566G2, Rbm34 gRNA vector 2 in pCas-Guide vector
- KN314566D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Olsen,J.V., (2006) Cell 127 (3), 635-648

Western Blot analysis of RBM34 expression in transfected 293T cell line (H00023029-T01) by RBM34 MaxPab polyclonal antibody.Lane 1: RBM34 transfected lysate(46.75 KDa).Lane 2: Non-transfected lysate.

Human HeLa; WB Suggested Anti-RBM34 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: Hela cell lysate. There is BioGPS gene expression data showing that RBM34 is expressed in HeLa.; RBM34 antibody - C-terminal region (ARP40798_P050) in Human HeLa cells using Western Blot

Western blot analysis of RBM34 expression in HeLa (A); mouse liver (B); H9C2 (C) whole cell lysates.

Western blot analysis of extracts from NIH/3T3 cells, using RBM34 antibody.The lane on the right is treated with the synthesized peptide.

Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using RBM34 antibody.The picture on the right is treated with the synthesized peptide.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA315214 | RBM34 antibody |
||||||
| Rabbit polyclonal anti-RBM34 antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms | E, P, WB |
0.1 ml /
$335.00
|
|
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||




+1 additional image